Zobrazeno 1 - 10
of 71
pro vyhledávání: '"Rathi V, Iyer"'
Autor:
Claudio Ramaciotti, Rathi V. Iyer, Julie Kanter, Michael M. Dowling, Fenella J. Kirkham, William Owen, Melissa Rhodes, Charles T. Quinn, Ifeyinwa Osunkwo, Sharada A. Sarnaik, C. Johnson, Linda S. Hynan, Nomazulu Dlamini, Julie A. Panepinto, Janet L. Kwiatkowski, Lynne Neumayr, Patricia Plumb, John J. Strouse, Baba Inusa
Publikováno v:
British Journal of Haematology. 176:300-308
Paradoxical' embolization via intracardiac or intrapulmonary right-to-left shunts (RLS) is an established cause of stroke. Hypercoagulable states and increased right heart pressure, which both occur in sickle cell anaemia (SCA), predispose to paradox
Autor:
Russell E. Ware, Pamela B. Sylvestre, Scott T. Miller, Karen Kesler, Zora R. Rogers, Peter A. Lane, Janet L. Kwiatkowski, William H. Schultz, Banu Aygun, Nicole A. Mortier, Alan R. Cohen, Alexandre Lockhart, Rathi V. Iyer, Ofelia A. Alvarez
Publikováno v:
British Journal of Haematology. 169:262-266
Serial phlebotomy was performed on sixty children with sickle cell anaemia, stroke and transfusional iron overload randomized to hydroxycarbamide in the Stroke With Transfusions Changing to Hydroxyurea trial. There were 927 phlebotomy procedures with
Publikováno v:
Clinical Pediatrics. 53:89-94
Autor:
Samantha Webb, Rathi V. Iyer, Venkat Krishna Reddy Mannam, Suvankar Majumdar, Erin W. Norcross, Naveed Ahmad, Seth T. Lirette
Publikováno v:
Pediatric Blood & Cancer. 60:1192-1197
Background Overt stroke in sickle cell anemia (SCA) is associated with intracranial stenosis and thrombus formation. Platelet activation is critical for thrombus formation. Procedure Platelet activation studies were performed in 50 subjects: 18 SCA p
Autor:
Brigit Brand, Alessandro Gringeri, Paul Giangrande, James J. Goedert, Michael Recht, Olga Katsarou, Ana Rosa Cid-Haro, Patrick F. Fogarty, Steven M. Wolinsky, Evelien P. Mauser-Bunschoten, Judith Lin, Kate Talks, Javier Martinez-Picado, Amy D. Shapiro, Amalio Telenti, Christine L. Kempton, Lucy Dorrell, David Goldstein, Jérôme Lane, Jerry S. Powell, Sara Colombo, Judith Dalmau, Jeremy J. Martinson, Johannes Oldenburg, Shehnaz K. Hussain, Barton F. Haynes, Michael Makris, Dimitrios A. Tsakiris, Amanda Stemke, Anne T. Neff, Stephen Moore, Shinichi Oka, Philip Kuriakose, Rathi V. Iyer, Jonathan T. Wilde, Peter William Collins, Maria Teresa Alvarez-Roman, Andrew J. McMichael, Rafael Parra, Françoise Boehlen, Paul J. McLaren, Deborah L Brown, Marilyn J. Manco-Johnson, Thynn Thynn Yee, Kimo C. Stine, Bonaventura Clotet, Kimberly Pelak, Jay H. Bream, Kristiina Peter-Salonen, Paula H B Bolton-Maggs, Elaine Y. Chiang, Lisa P. Jacobson, Mary Carrington, Lara Oyesiku, Anne Angelillo-Scherrer, Jacques Fellay, Kevin V. Shianna
Publikováno v:
Lane, Jérôme; McLaren, Paul J.; Dorrell, Lucy; Shianna, Kevin V.; Stemke, Amanda; Pelak, Kimberly; Moore, Stephen; Oldenburg, Johannes; Boehlen, Francoise; Alvarez-Roman, Maria Teresa; Angelillo-Scherrer, Anne; Bolton-Maggs, Paula H. B.; Brand, Brigit; Brown, Deborah; Chiang, Elaine; Cid-Haro, Ana Rosa; Clotet, Bonaventura; Collins, Peter; Colombo, Sara; Dalmau, Judith; ... (2013). A genome-wide association study of resistance to HIV infection in highly exposed uninfected individuals with hemophilia A. Human molecular genetics, 22(9), pp. 1903-1910. Oxford University Press 10.1093/hmg/ddt033
Human Molecular Genetics, Vol. 22, No 9 (2013) pp. 1903-1910
Human molecular genetics
Human Molecular Genetics, vol. 22, no. 9, pp. 1903-1910
Human Molecular Genetics, Vol. 22, No 9 (2013) pp. 1903-1910
Human molecular genetics
Human Molecular Genetics, vol. 22, no. 9, pp. 1903-1910
Human genetic variation contributes to differences in susceptibility to HIV-1 infection. To search for novel host resistance factors, we performed a genome-wide association study (GWAS) in hemophilia patients highly exposed to potentially contaminate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d1c24750bfdac52d92b3d5e567a3f03
https://doi.org/10.1093/hmg/ddt033
https://doi.org/10.1093/hmg/ddt033
Autor:
Russell E. Ware, Rathi V. Iyer, Bruce W. Thompson, Phillip Seaman, Scott T. Miller, Winfred C. Wang, Beatrice Files, Ofelia A. Alvarez, Jeffrey D. Lebensburger, Zhaoyu Luo, Courtney D. Thornburg, Ram Kalpatthi
Publikováno v:
Blood. 120:4304-4310
The Pediatric Hydroxyurea Phase 3 Clinical Trial (BABY HUG) was a phase 3 multicenter, randomized, double-blind, placebo-controlled clinical trial of hydroxyurea in infants (beginning at 9-18 months of age) with sickle cell anemia. An important secon
Autor:
Corina E. Gonzalez, Gerald M. Woods, Karen Kalinyak, Julie A. Panepinto, Hernan Sabio, Melissa Rhodes, Sharada A. Sarnaik, Allison A. King, Françoise Bernaudin, Gladstone Airewele, Michael J. Noetzel, James F. Casella, Rupa Redding-Lallinger, Janet K. Kwiatkowski, Beng Fuh, Mae O. Gordon, Charles T. Quinn, J. Phillip Miller, Mark Rodeghier, Mark E. Heiny, Fenella J. Kirkham, Suzanne Saccente, Baba Inusa, Jason Fixler, Caterina P. Minniti, Rebecca Ichord, Alexis A. Thompson, Paul Telfer, Thomas H. Howard, John J. Strouse, Michael R. DeBaun, Melanie Kirby-Allen, Rathi V. Iyer
Publikováno v:
Blood. 119:3684-3690
The most common form of neurologic injury in sickle cell anemia (SCA) is silent cerebral infarction (SCI). In the Silent Cerebral Infarct Multi-Center Clinical Trial, we sought to identify risk factors associated with SCI. In this cross-sectional stu
Autor:
Zora R. Rogers, James F. Casella, Ming Lu, R. Clark Brown, Sharada A. Sarnaik, Rathi V. Iyer, Winfred C. Wang, Scott T. Miller, Thomas H. Howard, Jeffrey D. Lebensburger
Publikováno v:
Pediatric Blood & Cancer. 59:675-678
Background Clinical complications of sickle cell anemia begin in infancy. BABY HUG (ClinicalTrials.gov, NCT00006400) was a NHLBI-NICHD supported randomized phase III placebo-controlled trial of hydroxyurea (HU) in infants (recruited at 9–18 months)
Autor:
Ronald W. Helms, Rathi V. Iyer, Zora R. Rogers, Scott T. Miller, Russell E. Ware, Nicole A. Mortier, Myron A. Waclawiw, Lee Hilliard, William H. Schultz, Nancy A. Yovetich, J. Paul Scott, Ofelia A. Alvarez
Publikováno v:
Pediatric Blood & Cancer. 57:1011-1017
Background Stroke occurs in 5–10% of children with sickle cell anemia (SCA) and has a high (>50%) risk of recurrence without therapy. Chronic monthly erythrocyte transfusions effectively prevent recurrent stroke, but their long term use is limited
Autor:
Scott T. Miller, Rathi V. Iyer, Russell E. Ware, Zora R. Rogers, Bea Files, Barry L. Shulkin, John H. Miller, Eglal Shalaby-Rana, Winfred C. Wang, Bruce W. Thompson, Zhaoyu Luo, Peter A. Lane, Stephen D. Dertinger
Publikováno v:
Blood. 117:2614-2617
We evaluated spleen function in 193 children with sickle cell anemia 8 to 18 months of age by 99mTc sulfur-colloid liver-spleen scan and correlated results with clinical and laboratory parameters, including 2 splenic biomarkers: pitted cell counts (P